R W Laing
Overview
Explore the profile of R W Laing including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
414
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Robinson D, Zakeri R, Brown L, Laing R, Choh C, Askari A, et al.
Ann R Coll Surg Engl
. 2024 Apr;
106(7):610-619.
PMID: 38634225
Introduction: Surgical training programmes in the United Kingdom and Ireland (UK&I) are in a state of flux. This study aims to report the contemporary opinions of trainee and consultant surgeons...
3.
Trivedi P, Reece J, Laing R, Slaney E, Cooney R, Gunson B, et al.
Aliment Pharmacol Ther
. 2018 Jun;
48(3):322-332.
PMID: 29882252
Background: Liver transplantation is the only life-extending intervention for primary sclerosing cholangitis (PSC). Given the co-existence with colitis, patients may also require colectomy; a factor potentially conferring improved post-transplant outcomes....
4.
Mergental H, Perera M, Laing R, Muiesan P, Isaac J, Smith A, et al.
Am J Transplant
. 2016 May;
16(11):3235-3245.
PMID: 27192971
The demand for liver transplantation (LT) exceeds supply, with rising waiting list mortality. Utilization of high-risk organs is low and a substantial number of procured livers are discarded. We report...
5.
Laing R, Scalera I, Isaac J, Mergental H, Mirza D, Hodson J, et al.
Am J Transplant
. 2016 Jan;
16(6):1795-804.
PMID: 26725645
The use of livers from donation after circulatory death (DCD) is increasing, but concerns exist regarding outcomes following use of grafts from "marginal" donors. To compare outcomes in transplants using...
6.
Stewart A, Drinkwater K, Laing R, Nobes J, Locke I
Clin Oncol (R Coll Radiol)
. 2015 Mar;
27(6):330-6.
PMID: 25727645
Aims: This audit provides a comprehensive overview of UK prostate brachytherapy practice in the year 2012, measured against existing standards, immediately before the introduction of new Royal College of Radiologists...
7.
Sooriakumaran P, Macanas-Pirard P, Bucca G, Henderson A, Langley S, Laing R, et al.
Cancer Genomics Proteomics
. 2009 May;
6(2):93-9.
PMID: 19451093
Background: We performed a pilot study, looking at the COX-2 inhibitor celecoxib, on newly diagnosed prostate cancer patients in the neo-adjuvant setting using DNA microarray analysis. Patients And Methods: This...
8.
Nobes J, Langley S, Laing R
Clin Oncol (R Coll Radiol)
. 2008 Dec;
21(3):183-91.
PMID: 19111451
Androgen deprivation therapy is widely used in a number of different settings in the treatment of prostate cancer. This overview will look at the current evidence for the potential development...
9.
Nobes J, Wells I, Khaksar S, Money-Kyrle J, Laing R, Langley S
Prostate Cancer Prostatic Dis
. 2008 Apr;
12(1):61-6.
PMID: 18427571
A total of 1200 patients had undergone I-125 prostate brachytherapy (BXT) in our centre. We present prospective outcome data for the first 400 treated patients. Data were analysed from a...
10.
Voulgaris S, Nobes J, Laing R, Langley S
Prostate Cancer Prostatic Dis
. 2008 Mar;
11(3):237-40.
PMID: 18364676
This article on low dose rate (LDR) prostate brachytherapy reviews long-term results, patient selection and quality of life issues. Mature results from the United States and United Kingdom are reported...